The Journal of Nuclear Medicine

Neuroinflammatory PET in Epilepsy: Prospects for Epileptogenic Zone Localization and Presurgical Planning

Pub Date : 2026-07-30 DOI: 10.2967/jnumed.126.272805 Callum Taylor, Bianca Jupp, Lucy Vivash

Tumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial

Pub Date : 2026-07-30 DOI: 10.2967/jnumed.126.272574 Zachary Ells, Catherine Meyer, Karam Masri, Marc Ryhiner, David Sennung, Koichiro Kimura, David Mirando, Izabela Tworowska, Rouzbeh Esfandiari, Martin S. Allen-Auerbach, Michael Lassmann, Ken Herrmann, Matthias Eiber, Wolfgang P. Fendler, Ebrahim Delpassand, Johannes Czernin, Magnus Dahlbom, Jeremie Calais

A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [177Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)

Pub Date : 2026-07-30 DOI: 10.2967/jnumed.126.272714 Sobia Khan, Nathan Papa, Takanori Hioki, Megan Crumbaker, Sze-Ting Lee, Andrew Weickhardt, Shikha Sharma, Shraddha Weir, Katharina Luckerath, Edmond Kwan, Louise Emmett